X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

MOLECULAR CANCER RESEARCH

期刊標題檢索 MOL CANCER RES 最新評論: Recently, a large number of articles from the journal Molecular Cance... (2024-05-16)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[MOLECULAR CANCER RESEARCH]您好,您是該頁面的第 78066 位訪客。

期刊簡介
期刊名稱MOLECULAR CANCER RESEARCH MOLECULAR CANCER RESEARCH
LetPub Score
7.5
50 ratings
Rate

Reputation
8.8

Influence
6.5

Speed
7.0

期刊簡稱MOL CANCER RES
ISSN1541-7786
E-ISSN1557-3125
h-index124
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.901.6600.870
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q163 / 404
Category: Medicine
Subcategory: Molecular Biology
Q177 / 410
Category: Medicine
Subcategory: Cancer Research
Q154 / 230

自引率 (2023-2024)2.40%自引率趨勢
掲載範囲
Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.
官方網站http://mcr.aacrjournals.org/
在線稿件提交http://mcr.msubmit.net/cgi-bin/main.plex
開放訪問No
出版商American Association for Cancer Research Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年2002
每年文章數102每年文章數趨勢
黃金OA百分比21.20%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ284/205
ONCOLOGYSCIEQ291/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1541-7786%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【MOLECULAR CANCER RESEARCH】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS MOLECULAR CELL BIOLOGYH-index: 386

    CiteScore: 173.60
    CELL RESEARCHH-index: 143

    CiteScore: 53.90
    Cell Stem CellH-index: 212

    CiteScore: 37.10
    NATURE CELL BIOLOGYH-index: 337

    CiteScore: 28.40
    AutophagyH-index: 121

    CiteScore: 21.30
    TRENDS IN CELL BIOLOGYH-index: 215

    CiteScore: 32.00
    JOURNAL OF CELL BIOLOGYH-index: 353

    CiteScore: 12.60
    CURRENT OPINION IN CELL BIOLOGYH-index: 242

    CiteScore: 14.60
    CELL PROLIFERATIONH-index: 66

    CiteScore: 14.80
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYH-index: 142

    CiteScore: 10.70
    學科內最受檢索的期刊 頁面查看次數
    Oxidative Medicine and Cellular Longevity248148
    CELL RESEARCH237698
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE184514
    BIOSCIENCE REPORTS157791
    Autophagy154655
    EXPERIMENTAL CELL RESEARCH134892
    CELL PROLIFERATION134495
    NATURE CELL BIOLOGY127697
    MOLECULAR AND CELLULAR BIOCHEMISTRY115714
    PLANT AND CELL PHYSIOLOGY114824
  •  

    MOLECULAR CANCER RESEARCH MOLECULAR CANCER RESEARCH
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [MOLECULAR CANCER RESEARCH] 的評論撰寫評論
作者: Lucy Larkin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-16 15:50:53 評論於
Recently, a large number of articles from the journal Molecular Cancer Research have been posted on PubPeer for some unknown reason
(0) 讚! | Lucy Larkin

作者: 白玉mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-24 18:33:21 評論於
Hello, can you please send me an EndNote citation style file? 411619585*******. Thank you very much!
(0) 讚! | 白玉mio

作者: 白玉mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-24 14:12:29 評論於
Hello, could you please send me an EndNote reference format file, 411619585*******? Thank you very much~
(0) 讚! | 白玉mio

作者: 白玉mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 19:53:46 評論於
Can you please send the endnote reference file? 411619585*******. Thank you~
(0) 讚! | 白玉mio

作者: 云纵睿范


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-11 23:46:45 評論於
Already received reviewer comments so soon?
(0) 讚! | 云纵睿范

作者: 云纵睿范


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-11 09:12:06 評論於
About 4 days
(0) 讚! | 云纵睿范

作者: 西风雨菱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-03 17:35:12 評論於
How long does it take for the editors of MOLECULAR CANCER RESEARCH to consider? There has been no movement at all
(0) 讚! | 西风雨菱

作者: 璃月一钧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-20 14:39:58 評論於
Hello, can you please send me a copy of the EndNote reference format to square0920@163.com? Thank you~
(0) 讚! | 璃月一钧

作者: 飞月远航


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-17 16:43:57 評論於
Hello, I would also like a copy, email 1724870986*******
(0) 讚! | 飞月远航

作者: 雾都继忠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-13 16:00:30 評論於
Hello, can you please send me a copy of 952552975*******?
(0) 讚! | 雾都继忠

作者: 坠星同光


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-07 11:28:35 評論於
Status is Decision Sent to Author, are there any revisions? Where can I view the revisions?
(0) 讚! | 坠星同光

作者: 恨瑶殿下


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-06 10:14:42 評論於
I ended up in this situation because my submission was rejected
(0) 讚! | 恨瑶殿下

作者: Jim Peggy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-22 19:14:31 評論於
Can you tell me if this situation is under review or will it be rejected? I have encountered a similar situation
(0) 讚! | Jim Peggy

作者: Esther Jonah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-27 18:14:55 評論於
Acceptance of pure life insurance?
(0) 讚! | Esther Jonah

作者: Esther Jonah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-27 16:33:39 評論於
Please translate the following paragraph into English and Japanese, and title them ":" and ":"
(0) 讚! | Esther Jonah

作者: Esther Jonah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-27 08:23:13 評論於
Acceptance of pure life insurance?
(0) 讚! | Esther Jonah

作者: 平原映风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-17 20:54:07 評論於
I have a question
(0) 讚! | 平原映风

作者: Elton Juliana


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-23 11:53:08 評論於
Hello, I need a copy. Can you send one to me? Thank you
(0) 讚! | Elton Juliana

作者: 恨瑶殿下


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-25 13:53:44 評論於
Has it been rejected? Is the rejection email only sent to the corresponding author?
(0) 讚! | 恨瑶殿下

作者: 龟甲桂芝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-07 17:10:07 評論於
Was it rejected?
(0) 讚! | 龟甲桂芝

作者: 璃沙清一


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-22 20:26:58 評論於
Hello, can you please send me the Endnote reference file? 1910952393******* Thank you very much
(0) 讚! | 璃沙清一

作者: Arlene Henrietta


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-01 18:01:07 評論於
Hello, may I ask for an EndNote reference format? 949600672@qq.com, thank you!
(0) 讚! | Arlene Henrietta

作者: Arlene Henrietta


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-01 09:08:59 評論於
Hello, could you please send me an Endnote reference format? 949600672@qq.com, thank you!
(0) 讚! | Arlene Henrietta

作者: 日光恨文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-19 20:38:55 評論於
I have encountered the status of "Waiting for potential reviewers Assignment" and I don't know what it means
(0) 讚! | 日光恨文

作者: 东京芳宁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-13 10:19:49 評論於
1479640938@qq.com Thank you
(0) 讚! | 东京芳宁

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [MOLECULAR CANCER RESEARCH] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*